137 related articles for article (PubMed ID: 15652456)
21. Role of molecular markers and gene profiling in head and neck cancers.
Gold KA; Kim ES
Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
[TBL] [Abstract][Full Text] [Related]
22. Unraveling the chromosomal aberrations of head and neck squamous cell carcinoma: a review.
Patmore HS; Cawkwell L; Stafford ND; Greenman J
Ann Surg Oncol; 2005 Oct; 12(10):831-42. PubMed ID: 16132373
[TBL] [Abstract][Full Text] [Related]
23. Mouse models for human head and neck squamous cell carcinomas.
Lu SL; Herrington H; Wang XJ
Head Neck; 2006 Oct; 28(10):945-54. PubMed ID: 16721744
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
[TBL] [Abstract][Full Text] [Related]
25. Bladder cancer, a two phased disease?
Höglund M
Semin Cancer Biol; 2007 Jun; 17(3):225-32. PubMed ID: 16574430
[TBL] [Abstract][Full Text] [Related]
26. The role of genetic factors in predisposition to squamous cell cancer of the head and neck.
Jefferies S; Eeles R; Goldgar D; A'Hern R; Henk JM; Gore M
Br J Cancer; 1999 Feb; 79(5-6):865-7. PubMed ID: 10070882
[TBL] [Abstract][Full Text] [Related]
27. Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies.
Rivera RS; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Pehlivan D; Yamanaka N; Shimizu K; Nagai N
Oncol Rep; 2008 May; 19(5):1079-84. PubMed ID: 18425361
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary preneoplasia--sequential molecular carcinogenetic events.
Lantuéjoul S; Salameire D; Salon C; Brambilla E
Histopathology; 2009 Jan; 54(1):43-54. PubMed ID: 19187179
[TBL] [Abstract][Full Text] [Related]
29. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility.
Lacko M; Oude Ophuis MB; Peters WH; Manni JJ
Anticancer Res; 2009 Feb; 29(2):753-61. PubMed ID: 19331232
[TBL] [Abstract][Full Text] [Related]
31. [Usefulness of cryosurgery in preneoplastic and neoplastic pathology of the head and neck region].
Scala M; Margarino G; Amoretti G; Mereu P; Mereto G
Minerva Chir; 1987 Mar; 42(5):369-77. PubMed ID: 3601118
[No Abstract] [Full Text] [Related]
32. Transforming Growth Factor-alpha reduces carcinogen-induced DNA damage in mini-organ cultures from head-and-neck cancer patients.
Baumeister P; Schwenk-Zieger S; Reiter M; Welz C; Harréus U
Mutat Res; 2009; 677(1-2):42-5. PubMed ID: 19539778
[TBL] [Abstract][Full Text] [Related]
33. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
34. The surgical pathology of head and neck cancer.
Zarbo RJ; Crissman JD
Semin Oncol; 1988 Feb; 15(1):10-9. PubMed ID: 3278387
[No Abstract] [Full Text] [Related]
35. The role of CSMD1 in head and neck carcinogenesis.
Scholnick SB; Richter TM
Genes Chromosomes Cancer; 2003 Nov; 38(3):281-3. PubMed ID: 14506705
[No Abstract] [Full Text] [Related]
36. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
38. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas.
Martone T; Gillio-Tos A; De Marco L; Fiano V; Maule M; Cavalot A; Garzaro M; Merletti F; Cortesina G
Clin Cancer Res; 2007 Sep; 13(17):5089-94. PubMed ID: 17785562
[TBL] [Abstract][Full Text] [Related]
39. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
[TBL] [Abstract][Full Text] [Related]
40. Role of impaired DNA repair in genotoxic susceptibility of patients with head and neck cancer.
Rusin P; Olszewski J; Morawiec-Bajda A; Przybylowska K; Kaczmarczyk D; Golinska A; Majsterek I
Cell Biol Toxicol; 2009 Oct; 25(5):489-97. PubMed ID: 18787964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
